Although the median age of women diagnosed with breast cancer is 61 years, about 35% of women newly diagnosed with breast cancer are 54 years or younger, and 12%—almost 25 000—are younger than 45 years.1 The majority of women with breast cancer will receive adjuvant therapy including chemotherapy, hormone therapy, or both, which has been documented to improve disease-free and overall survival. Treatment has a number of adverse effects that directly affect short-term and, in some cases, long-term quality of life. For young women of childbearing age, one of the most devastating adverse effects involves the prospect of loss of fertility, and this concern may influence choice of therapy and adherence to a prescribed treatment plan.2 For some women, concern about early menopause is paramount.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 6
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Users' Guides to the Medical Literature
Table 9.2-2 Refuted Evidence From Studies of Physiologic or Surrogate Endpoints
The Rational Clinical Examination
Make the Diagnosis: Breast Cancer
All results at
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.